You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Our Global Impact

280M patients' lives touched globally*

Nearly 52M patients and consumers globally use J&J Vision products

Nearly 60,000 employees worldwide

Selling products in virtually all countries

$27B in 2021 sales

24 institutes on 5 continents training >125,000 HCPs globally
Using Our Breadth and Scale To Impact Global Healthcare Needs
32%
32% of the global burden of disease can be attributed to surgically treatable conditions
250M
Osteoarthritis affects 250M people globally, and is a leading cause of disability2
1.8M
Lung cancer is the most commonly diagnosed cancer worldwide, responsible for 1.8M deaths in 20183
1 in 4
1 in 4 adults over the age of 40 is at risk of developing AFib4
13.7M
13.7M people experience their first stroke every year5
2.2B
Globally, 2.2 billion people are visually impaired
Reimagining the Way Healthcare Is Delivered, and Helping People Live Longer, Healthier Lives
Our Focus Areas Include:

Orthopaedics
We provide one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve while delivering clinical and economic value to healthcare systems worldwide. Specialties include joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine.

Surgery
We deliver innovative surgical technologies and solutions to surgeons and healthcare professionals around the world to effectively treat some of the world’s most prevalent conditions such as obesity, cardiovascular disease, and cancer.

Cardiovascular, Stroke & Specialty Solutions
Our portfolio encompasses a range of innovative business segments that support professionals with tools for neurovascular care, heart rhythm disorders, ear, nose and throat treatment, and breast reconstruction.

Eye Health
We bring together cutting-edge insights, science, technology, and people to encourage eye care professionals and patients to proactively protect, correct, and enhance healthy sight for life. Our products and services address needs at every stage – from the pediatric to aging eye – in a patient’s lifetime.
Continually Focusing on Elevating the Standard of Care

Innovating at the Forefront of Science and Technology

Developing Connected Products and Solutions Across the Entire Patient Journey

Leveraging Data and Insights with the Goal of Lowering Costs, Increasing Access and Improving Outcomes

We are building leading-edge capabilities in digital surgery positioning us for success over the long term. Our vision is to shape a future where medical intervention is smarter, less invasive and more personalized.
Committed to Improving the Communities Where We Live and Work
At the community level, the Johnson & Johnson MedTech companies work with physician, patient and community partners to provide life-enhancing, life-saving services to people in need.
American Heart Association
Operation Smile
Sight for Kids
HCP Cure Blindness
Save the Children
Susan G. Komen®
Meet the Leaders

Ashley McEvoy
Executive Vice President
Worldwide Chairman
Johnson & Johnson MedTech

Vladimir Makatsaria
Company Group Chairman
Ethicon

Aldo Denti
Company Group Chairman
DePuy Synthes

Shlomi Nachman
Company Group Chairman
CSS and J&J Vision

Hani Abouhalka
Company Group Chairman
Robotics & Digital Solutions

Mark Benson
Worldwide VP
Supply Chain

Liz Blackwood
Chief Quality Officer
VP, Quality & Compliance

Lisa Blair Davis
Global Head HR

Luly de Samper
International VP
LATAM

Stephanie Hartgrove
Global Leader
Communication & Public Affairs

Larry Jones
SVP & Group CIO

Celine Martin
Company Group Chairman
Cardiovascular & Specialty
Solutions Group

Peter Menziuso
Company Group Chairman
J&J Vision

Susan Morano
VP, Business Development
and Strategic Operations

Tim Schmid
Company Group Chairman
APAC

Peter Schulam
Global Head, Medical Affairs,
Clinical Affairs and
Pre-Clinical Research

Peter Shen
Global Head R&D

Kurt Van den Bosch
Chief Financial Officer
Group Finance

Ashley Watson
General Counsel

Gavin Wood
Company Group Chairman
EMEA
References
- The Lancet Global Surgery Commission, 2015; The Lancet, November 2014
- Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-1759.
- The Cancer Atlas. Lung Cancer. https://canceratlas.cancer.org/the-burden/lung-cancer/
- Lloyd-Jones, Donald M., et al. “Lifetime risk for development of atrial fbrillation: the Framingham Heart Study.” Circulation110.9 (2004):1042-1046.
- Learn about stroke. World Stroke Organization. www.world-stroke.org https://www.world-stroke.org/world-stroke-day-campaign/why-stroke-matters/learnabout-stroke.
- The Challenge of Providing Spectacles in the Developing World. Brien Holden, PhD DSc OAM, et al; Community Eye Health, 2000
*Data are an approximate number according to Johnson & Johnson global internal unit volume across platforms.
The third party trademarks used herein are the trademarks of their respective owners.
173141-210407 DSUS
© Johnson & Johnson Services, Inc. 2021.